AMNIVUZ

Serial Number 99161396
641

Registration Progress

Application Filed
Apr 29, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AMNIVUZ

Basic Information

Serial Number
99161396
Filing Date
April 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jun 24, 2025
Application
Pending
Classes
005

Rights Holder

Amgen Inc.

03
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Legal Representation

Attorney
Elsa D. Lemoine

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Jun 25, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jun 25, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 29, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 29, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 29, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders; pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke

Classification

International Classes
005